Interleukin-22 Treatment Promotes Intestinal Stem Cell-Mediated Epithelial Regeneration Via Stat3 Activation and Reduces GI Gvhd

Caroline A. Lindemans(University Medical Center Utrecht), Alan M. Hanash(Memorial Sloan Kettering Cancer Center), Marcel R.M. van den Brink(City Of Hope National Medical Center), Marco Calafiore(Memorial Sloan Kettering Cancer Center), Margaret O'Connor(Memorial Sloan Kettering Cancer Center), Anna Mertelsmann(University of Zurich)
Transplantation and Cellular Therapy
February 18, 2016
10.1016/j.bbmt.2015.11.345
Cited by 6

Related Papers

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration
|Nature|2015|1.1k
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762